A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra (GCF-041)
A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects Treated With Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent
Sponsor: Glaukos Corporation
Terminated
Business decision
Other terminated trials from Glaukos Corporation
- Primary Open Angle Glaucoma (POAG) · Phase NA · Dec 2020
- Primary Open-Angle Glaucoma · Phase NA · Aug 2020
- Myopia · Phase NA · Jan 2018
- Keratoconus · Phase PHASE3 · Apr 2017
- Hyperopia · Phase PHASE1/PHASE2 · Apr 2016
More terminations from Glaukos Corporation
Other Glaucoma, Open-Angle trials with similar outcome
This NA trial investigates Glaucoma, Open-Angle and is currently terminated or withdrawn. Glaukos Corporation leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Mar 2022 — Sep 2022 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Feb 2020 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Sep 2017 — Jan 2018 [monthly]
Recruiting PHASE4
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Glaukos Corporation
For direct contact, visit the study record on ClinicalTrials.gov .